Scilex Holding Company
SCLXNASDAQHealthcare● Active
$6.91
$-0.09(-1.29%)
Market Cap$58674676
P/E Ratio—
52W High$34.27
52W Low$4.2
Scilex Holding Company (SCLX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SCLX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 20, 2026EPS Actual
-$4.76
Est. -$0.34 · -1311.2%
Revenue
$0.01B
Est. $0.01B · -42.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 20, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
SCLX reports quarterly as a NASDAQ-listed Drug Manufacturers - General company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.29 | — | — | — | $0.02B | — |
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.29 | — | — | — | $0.02B | — |
| ▼ Q2 FY2026 | May 20, 2026 | -$0.34 | -$4.76 | -1311.2% | $0.01B | $0.01B | -42.6% |
| ▼ Q2 FY2026 | Apr 10, 2026 | -$0.47 | -$4.60 | -878.7% | $0.00B | $0.01B | -60.4% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -$0.47 | -$22.17 | -4617.0% | $0.01B | $0.01B | -12.7% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.41 | -$7.42 | -1709.8% | $0.01B | $0.03B | -62.3% |
| ▲ Q2 FY2025 | May 14, 2025 | -$4.20 | -$2.26 | +46.2% | $0.01B | $0.01B | +0.0% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -$0.10 | -$0.25 | -150.0% | $0.01B | $0.02B | -16.2% |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.29
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.29
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 20, 2026Miss
EPS Actual
-$4.76
EPS Est.
-$0.34
EPS Surpr.
-1311.2%
Revenue
$0.01B
Q2 FY2026
Apr 10, 2026Miss
EPS Actual
-$4.60
EPS Est.
-$0.47
EPS Surpr.
-878.7%
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
-$22.17
EPS Est.
-$0.47
EPS Surpr.
-4617.0%
Revenue
$0.01B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$7.42
EPS Est.
-$0.41
EPS Surpr.
-1709.8%
Revenue
$0.01B
Q2 FY2025
May 14, 2025Beat
EPS Actual
-$2.26
EPS Est.
-$4.20
EPS Surpr.
+46.2%
Revenue
$0.01B
Q1 FY2025
Mar 31, 2025Miss
EPS Actual
-$0.25
EPS Est.
-$0.10
EPS Surpr.
-150.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.70 | $1.70 | $1.70 | 1 |
| Q3 FY2028 | $1.69 | $1.69 | $1.69 | 1 |
| Q2 FY2028 | $1.75 | $1.75 | $1.75 | 1 |
| Q1 FY2028 | $1.64 | $1.64 | $1.64 | 1 |
| Q4 FY2027 | $0.14 | $0.14 | $0.14 | 1 |
| Q3 FY2027 | $0.18 | $0.18 | $0.18 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 20, 2026 | -1311.2% | $5.98 | $6.01 | +0.50% |
| ▼ Q2 FY2026 | Apr 10, 2026 | -878.7% | $7.01 | $6.80 | -3.00% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -4617.0% | $17.87 | $17.69 | -1.01% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -1709.8% | $17.67 | $21.00 | +18.85% |
| ▲ Q2 FY2025 | May 14, 2025 | +46.2% | $4.19 | $4.47 | +6.68% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -150.0% | $8.52 | $8.70 | +2.11% |
| ▼ Q1 FY2025 | Jan 17, 2025 | -3600.0% | $16.42 | $15.72 | -4.26% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +10.0% | $46.20 | $45.85 | -0.76% |
Q2 FY2026+0.50%
Report Date
May 20, 2026
EPS Beat/Miss
-1311.2%
Price Before
$5.98
Price After
$6.01
Q2 FY2026-3.00%
Report Date
Apr 10, 2026
EPS Beat/Miss
-878.7%
Price Before
$7.01
Price After
$6.80
Q4 FY2025-1.01%
Report Date
Nov 14, 2025
EPS Beat/Miss
-4617.0%
Price Before
$17.87
Price After
$17.69
Q3 FY2025+18.85%
Report Date
Aug 13, 2025
EPS Beat/Miss
-1709.8%
Price Before
$17.67
Price After
$21.00
Q2 FY2025+6.68%
Report Date
May 14, 2025
EPS Beat/Miss
+46.2%
Price Before
$4.19
Price After
$4.47
Q1 FY2025+2.11%
Report Date
Mar 31, 2025
EPS Beat/Miss
-150.0%
Price Before
$8.52
Price After
$8.70
Q1 FY2025-4.26%
Report Date
Jan 17, 2025
EPS Beat/Miss
-3600.0%
Price Before
$16.42
Price After
$15.72
Q3 FY2024-0.76%
Report Date
Aug 13, 2024
EPS Beat/Miss
+10.0%
Price Before
$46.20
Price After
$45.85
Avg Beat Reaction+2.96%
Avg Miss Reaction+2.20%
Beat Rate2 / 8 quarters
Largest Move+18.85% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SCLX ends December
Scilex Holding Company (SCLX) most recently reported earnings on May 20, 2026 for Q2 FY2026, posting EPS of $-4.76 — missing the analyst consensus of $-0.34 by -1311.2%. The next SCLX earnings date is expected around September 1, 2026.
Each quarter, investors track SCLX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SCLX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SCLX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SCLX earnings · 5 questionsScilex Holding Company's next earnings report is expected around September 1, 2026. SCLX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SCLX historically reports after market close (AMC).
SCLX earnings datewhen is SCLX earningsSCLX next earnings datewhen does SCLX report earningsSCLX earnings calendar
▸ Source: FMP · Scilex Holding Company SEC filings · US GAAP · Scilex Holding Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026